# Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/toxicity-assessment-of-a-phase-iii-study-evaluating-fec-doc-and-fec-doc-combined/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lennard Schröder,Brigitte Rack,H. Sommer,Julian Koch,T Weißenbacher,Wolfgang Janni,Andreas Schneeweiß,Mahdi Rezai,Ralf Lorenz,Bernadette Jäger,A Schramm,Lothar Häberle,P. Fasching,Thomas W. P. Friedl,M. Beckmann,C. Scholz |
| Citations | 10 |
| DOI | 10.1055/s-0042-106209 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-106209.pdf |
| OpenAlex ID | https://openalex.org/W2402380783 |
| PMID | 27239063 |
| Type | article |
| Year | 2016 |

## Paper authors

- [T Weißenbacher](https://scholariq.org/researchers/t-wei-enbacher/)

## Paper journal

- [Geburtshilfe und Frauenheilkunde](https://scholariq.org/journals/geburtshilfe-und-frauenheilkunde/)

## Paper primary topic

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Paper topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.